+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study



Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study



International Journal of Clinical Practice 60(12): 1596-1599



Vascular access thrombosis (VAT) is an important cause of morbidity for chronic haemodialysis (HD) patients. Some risk factors for VAT have been well-defined for chronic HD patients from western countries. However, only a few such factors have been confirmed for Taiwanese patients. This study attempted to determine the association between hyperhomocysteinaemia and the incidence of VAT for chronic HD patients in Taiwan.

(PDF emailed within 0-6 h: $19.90)

Accession: 013248888

Download citation: RISBibTeXText

PMID: 16704682

DOI: 10.1111/j.1742-1241.2006.00848.x


Related references

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study. Vascular Health and Risk Management 9: 361-364, 2013

IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients. Renal Failure 27(1): 25-30, 2005

Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients?. Nephrology, Dialysis, Transplantation 12(9): 2037-2038, 1997

Atrial fibrillation linked to vascular access thrombosis in chronic hemodialysis patients. Journal of Atherosclerosis and Thrombosis 18(6): 448-453, 2011

Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Therapeutic Apheresis and Dialysis 15(1): 40-43, 2011

Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients. International Urology and Nephrology 43(2): 499-505, 2011

Vascular access thrombosis is not related to presence of antiphospholipid antibodies in patients on chronic hemodialysis. Nephron 92(4): 957-958, 2002

Vascular Access Thrombosis Is Not Related to Presence of Antiphospholipid Antibodies in Patients on Chronic Hemodialysis. Nephron 92(4): 957-958, 2002

Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective study. International Journal of Clinical Practice 60(12): 1591-1595, 2006

Recombinant streptokinase treatment of thrombosis of the permanent vascular access in chronic renal insufficiency patients treated with periodic hemodialysis. Biotecnologia Aplicada 12(3): 195-196, 1995

Variable flow Doppler vascular access blood flow predicts vascular access thrombosis in hemodialysis patients with PTEE grafts. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 296A-297A, 2001

No association between hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis. Journal of Vascular Access 4(1): 14-20, 2003

Hyperhomocysteinemia and vascular access thrombosis in chronic hemodialysis Is there an association?. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 282A, 2000

Hemodialysis Vascular Access Creation in Patients Switching From Peritoneal Dialysis to Hemodialysis: A Population-Based Retrospective Cohort. American Journal of Kidney Diseases 67(5): 813-816, 2016

Are you SURE about your vascular access? Exploring factors influencing vascular access decisions with chronic hemodialysis patients and their nurses. Cannt Journal 26(2): 21-28, 2018